Skip to main content

Advertisement

Table 1 Clinicopathologic characteristics of patient samples in Cohorts 1 and 2

From: Overexpression of MACC1 and Its significance in human Breast Cancer Progression

Characteristic Cohort 1 Cohort 2
  NO. % NO. %
Total 245 185
Age  
 ≤45 95 38.8 78 42.2
 >45 150 61.2 107 57.8
Menopausal status  
 Premenopausal 116 53.2   
 Postmenopausal 102 46.8   
 Unknown 27    
Clinical stage  
 I 81 33.1 21 11.4
 II 91 37.1 80 43.2
 III 40 16.3 59 31.9
 IV 33 13.5 25 13.5
T classification  
 T1 110 44.9 36 19.5
 T2 107 43.7 92 49.7
 T3 18 7.3 41 22.2
 T4 10 4.1 16 8.6
N classification  
 N0 135 55.1 70 37.8
 N1 51 20.8 78 42.2
 N2 41 16.7 30 16.2
 N3 18 7.3 7 3.8
Distant metastasis  
 Yes 212 86.5 177 95.7
 No 33 13.5 8 4.3
Estrogen receptor  
 Positive 174 71.0 101 54.6
 Negative 71 29.0 84 45.4
 Unknown 0   0  
Progesterone receptor  
 Positive 146 66.3 110 59.5
 Negative 74 33.7 75 40.5
 Unkown 25   0  
Her2  
 Positive 43 22.3 21 21.4
 Negative 150 77.7 77 78.6
 Unknown 52   87  
MACC1 expression     
 High expression 136 55.5 111 60.0
 Low expression 109 44.5 74 40.0
Endocrine therapy  
 tamoxifen 122 43.8   
 No treatment 95 56.2   
 Unknown 28